Lemborexant 2.5 mg

DRUG2 trials

Sponsors

Eisai Inc.

Conditions

Healthy ParticipantsIrregular Sleep-Wake Rhythm Disorder

Phase 1

Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

CompletedNCT02583451

Eisai Inc.Healthy Participants

Start: 2015-11-30End: 2017-02-28Updated: 2018-09-06

Phase 2

Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

CompletedNCT03001557

Eisai Inc.Irregular Sleep-Wake Rhythm Disorder

Start: 2016-12-20End: 2020-04-17Updated: 2021-05-17

Related Papers

Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials

Drugs & Aging2024-08-0910 citations

Long‐term safety and efficacy of lemborexant in subjects with irregular sleep‐wake rhythm disorder and Alzheimer’s disease dementia

Alzheimer s & Dementia2020-12-01

F1‐06‐04: RESPONSE TO TREATMENT WITH LEMBOREXANT: SUBJECTS WITH IRREGULAR SLEEP‐WAKE RHYTHM DISORDER AND ALZHEIMER'S DISEASE DEMENTIA

Alzheimer s & Dementia2019-07-014 citations

On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers

SLEEP2018-12-31225 citations